Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer (Q33371306)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

title

Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

main subject

phase II clinical trial

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

K Nakamura

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

T Yamaguchi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

T Ishihara

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

K Sudo

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

H Kato

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

H Saisho

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

volume

94

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

page(s)

1575-1579

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

cites work

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361295

retrieved

21 June 2018

Nutritional interventions in cancer prevention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603168

retrieved

21 January 2018

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603168

retrieved

21 January 2018

An early phase II study of S-1 in patients with metastatic pancreatic cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603168

retrieved

21 January 2018

Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic Cancer Registry in Japan: 20 years of experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16721372

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6603168

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

Dimensions Publication ID

1016985566

0 references

PMC publication ID

2361295

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

PubMed publication ID

16721372

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16721372

retrieved

26 July 2017

ResearchGate publication ID

7062043

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33371306&oldid=2195295235"